Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2016-09-30
2017-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to measure the amount of convection achieved with two different haemodiafilters designed for haemodiafiltration and clotting during haemodiafiltration treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparative Study of Two Kinds of Hemodialysis Filters
NCT05899283
Impact of Clotting on Dialyzer Efficiency
NCT04746391
Coupling Between Clotting Characteristics in Chronic Hemodialysis Patients and the Hemodialyzer Patency
NCT05440201
Effect of Nephral 400 ST Dialysis Membrane on Coagulation in Hemodialysis
NCT00594607
Dialysis Performance of Different Dialyzer Membranes Using Different Coagulation Strategies
NCT03820401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SOLACEA 21H
single haemodiafiltration treatment using a SOLACEA 21H dialyzer (Nipro Corp, Osaka, Japan)
SOLACEA 21H
comparison of dialyzers
FX100
single haemodiafiltration treatment using a FX100 dialyzer (Fresenius MC, Bad Homburg, Germany)
FX100 dialyzer
comparison of dialyzers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FX100 dialyzer
comparison of dialyzers
SOLACEA 21H
comparison of dialyzers
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Under the care of the Royal Free Hospital with chronic kidney disease and established on regular thrice weekly haemodiafiltration.
* Able to provide written informed consent obtained
Exclusion Criteria
* Patients taking concomitant systemic anticoagulants
* Patients with known prothrombotic or bleeding disorders
* Patients with abnormal platelet counts
* Patients unable to provide written informed consent
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
andrew davenport
Role: PRINCIPAL_INVESTIGATOR
UCL centre for nephrology, Royal Free Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC: 08/H0724/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.